Cmed, the clinical research organisation and technology development company, has entered into a partnership agreement with Tessella.
Under the terms of the agreement, Tessella and Cmed will ensure interoperability of Timaeus, the intelligent data acquisition and management system (IDAM), with Tessella's fixed and adaptive trial execution system (FATES).
'With Timaeus, organisations have the ability to acquire, manage and report data in near-real time.
'This is particularly important for adaptive trials because it minimises the delay in the availability of response data and therefore adaptation of the trial,' said Tom Parke, head of clinical technologies at Tessella.
